D. E. SHAW & CO L.P. 13D/13G Filings for Ambrx Biopharma Inc. (AMAM)

D. E. SHAW & CO L.P. 13D and 13G filings for Ambrx Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-03-16
4:05 pm
Purchase		 2023-03-06 13G Ambrx Biopharma Inc.
AMAM		 D. E. SHAW & CO L.P. 22,050,000
8.200%		 22,050,000increase
(New Position)		 Filing